Skip to main content
. 2014 May 27;5(13):4765–4778. doi: 10.18632/oncotarget.2017

Table 1. IC50s of gefitinib and MK2206 for the NSCLC cell lines used in this study.

Cell line IC50 (μM ± SEM)
gefitinib MK2206
PC-9 0.07±8x10-2 1.18±0.23
HCC-827 0.03±8x10-5 2.25±0.25
A549 5.25±0.77 4.81±0.43
H1975 9.57±1.94 7.66±0.63